Themis Medicare Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Themis Medicare Limited with three other
companies in this sector in India:
Lasa Supergenerics Ltd
sales of 1.70 billion Indian Rupees [US$23.67 million]
Sun Pharma Advanced Research Company Limited.
(1.83 billion Indian Rupees [US$25.53 million]
of which 100%
was Pharmaceutical Research and Development), and
Syncom Formulations (India) Limited
(1.87 billion Indian Rupees [US$26.07 million]
Themis Medicare Limited reported sales of 1.84 billion Indian Rupees (US$25.65 million)
March of 2019.
decrease of 12.3%
versus 2018, when the company's sales were 2.10 billion Indian Rupees.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Themis Medicare Limited had sales
of 1.95 billion Indian Rupees.